Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Immix Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −1 vs. Q1 2022
- Shares held
- 183.5K
- +36.9K (+25.2%) vs. Q1 2022
- Total value
- $475.0K
- +$123.0K (+34.9%) vs. Q1 2022
- New holders
- 4
- 1 more added
- Sold out
- 5
- 0 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 73,333 | $190.0K | 0.00% | +73,333 | New |
| Vanguard Group Inc | 50,905 | $132.0K | 0.00% | +50,905 | New |
| State Street Corp | 38,560 | $100.0K | 0.00% | +38,560 | New |
| InterOcean Capital Group, LLC | 15,900 | $41.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,337 | $11.0K | 0.00% | +4,337 | New |
| Advisor Group Holdings, Inc. | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 70 | $0 | 0.00% | +44+169.2% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −62,600−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,515−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,713−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,992−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −9,415−100.0% | Sold out |